Supported by the UK Government's Global AMR Innovation Fund, each selected innovation will receive funding of up to £170,000, along with incubation, mentoring, and technology support to accelerate commercialisation
With access to over 1,500 healthcare products and savings of up to 90%compared to conventional market prices, the platform aims to help consumers reduce their healthcare expenses
The proposed joint venture will accelerate the launch of pharmaceutical and consumer healthcare products across South-East Asia, the Middle East, Africa, and other emerging markets
The facility comes at a time when demand for women's healthcare solutions is rising globally, driven by increasing awareness and diagnosis of hormonal disorders, growing demand for fertility treatments
The deal marks Strides' latest move to monetise high-growth businesses while retaining exposure to their future upside
Carotid artery disease accounts for up to 30% of all strokes
The Foundation says it is working alongside NGOs, healthcare professionals, patient groups, and local communities to build programs
Karkinos’ model aims to close both gaps by combining World Health Organization-recommended HPV DNA testing with a digitally enabled continuum of care
Centessa is a clinical-stage biotech focused on developing orexin receptor 2 agonists
BOTOX Cosmetic is providing participants with training resources, mentorship, and— for 20 selected founders— access to business-boosting capital
The offer is being made through Harmony Row Acquisition Co., a wholly owned GSK subsidiary, and targets all outstanding Class A and Class B shares of Nuvalent
Company secures 7th position nationwide in India's Great Mid-size Workplaces 2026, reinforcing its people-first culture as it marks 75 years of excellence
Partnership with Sunshine Healthcare aims to build local pharmaceutical capabilities and strengthen supply chain resilience
Nuvectis gains global rights outside select Asian markets for oncology and complement disease therapies, with Haisco eligible for milestone payments and royalties
The resolution significantly reduces a long-standing contingent liability from the company's books
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
The collaboration comes at a time when access to high-quality fertility treatment remains uneven, despite rapid market expansion
With this commissioning, Shilpa Medicare joins a very small group of Indian companies capable of offering end-to-end ADC Drug Substance development and manufacturing
The backing comes as influenza remains a persistent public health burden
After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average
Subscribe To Our Newsletter & Stay Updated
_195_291.png){kind=logo}
